Expression of metalloproteinases and inhibitors in the differentiation of P19CL6 cells into cardiac myocytes.
P19CL6 are a clonal derivative of P19 embryonal carcinoma cells, a euploid, multipotent mouse cell line, that differentiate efficiently into cardiac myocytes, with spontaneous beating evident within 10 days, following DMSO treatment. Using real-time quantitative RT-PCR we have profiled the expression of the complete matrix metalloproteinase and tissue inhibitor of metalloproteinase gene families during P19CL6 differentiation to cardiac myocytes. The genes subdivide into eight groups based upon their expression profile. Their expression was both qualitatively and quantitatively highly homologous to that seen during mouse heart development.
Young
David A
DA
School of Biological Sciences, University of East Anglia, Norwich NR4 7TJ, UK.
Gavrilov
Svetlana
S
Pennington
Caroline J
CJ
Nuttall
Robert K
RK
Edwards
Dylan R
DR
Kitsis
Richard N
RN
Clark
Ian M
IM
D000818:Animals; D002454:Cell Differentiation / Q000187:drug effects / Q000502:physiology; D045744:Cell Line, Tumor; D004121:Dimethyl Sulfoxide / Q000494:pharmacology*; D007700:Kinetics; D020782:Matrix Metalloproteinases / Q000187:drug effects / Q000378:metabolism*; D051379:Mice; D032342:Muscle Cells / Q000166:cytology* / Q000187:drug effects; D009206:Myocardium / Q000166:cytology*; D013724:Teratoma; D019714:Tissue Inhibitor of Metalloproteinases / Q000187:drug effects / Q000378:metabolism*
D019714:Tissue Inhibitor of Metalloproteinases; D020782:Matrix Metalloproteinases; D004121:Dimethyl Sulfoxide